Opioid Use Disorder Clinical Trials in Providence, Rhode Island

7 studies are recruiting for opioid use disorder in Providence, Rhode Island right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

   VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300 milligrams (mg) is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorph…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   Providence VA Medical Center, Providence, RI, Providence, Rhode Island

   Locations

   25 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT04375033 on ClinicalTrials.gov

2. A Study of Brenipatide in Participants With Opioid Use Disorder

   The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Brown University School of Public Health, Providence, Rhode Island

   Locations

   59 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07420283 on ClinicalTrials.gov

3. Personalized Addiction Treatment enHancement

   Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep pat…

   Stage

   Not phased

   Ages

   22 and older

   Site

   Rhode Island Hospital, Providence, Rhode Island

   Run by

   Rhode Island Hospital

   See if you can join NCT07778394 on ClinicalTrials.gov

4. tDCS to Decrease Opioid Relapse (UH3)

   Investigators will measure behavioral and brain responses following transcranial direct current stimulation (tDCS) to the dorsolateral prefrontal cortex (DLPFC) (anode on right DLPFC, cathode on the left DLPFC) delivered during cognitive control network (CCN) priming. In Phase I, the EEG provided v…

   Stage

   Not phased

   Ages

   21 to 60

   Site

   Butler Hospital, Providence, Rhode Island

   Run by

   Butler Hospital

   See if you can join NCT06432465 on ClinicalTrials.gov

5. Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose

   The investigators aim to test the effectiveness of a high maintenance daily dose of buprenorphine (24 mg) for improving outcomes among patients who used fentanyl compared to the standard daily dose (16 mg). The main question it aims to answer is: will patients who are randomly assigned to the high …

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Brown University, Providence, Rhode Island

   Run by

   Rhode Island Hospital

   See if you can join NCT06316830 on ClinicalTrials.gov

6. Emergency Medicine Peer Outreach Worker Engagement for Recovery

   This is an observational, prospective case-control study evaluating the effects of an emergency department community health worker-peer recovery specialist program (PCHW), the Substance Misuse Assistance Response Team (SMART). Aims of this study are to 1) understand participant experiences working …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Rhode Island Hospital, Providence, Rhode Island

   Run by

   University of California, Los Angeles

   See if you can join NCT06320015 on ClinicalTrials.gov

7. Opioid Treatment and Peer Recovery Support

   Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Brown University, Providence, Rhode Island

   Locations

   3 in total

   Run by

   Brown University

   See if you can join NCT04978168 on ClinicalTrials.gov